Resveratrol in Endometriosis: Inflammation, Angiogenesis, and Pain

A clear review of how this polyphenol acts on inflammation, angiogenesis, and pain in endometriosis, and what current scientific evidence shows.

1. Endometriosis: inflammation, angiogenesis, and pain

If you live with endometriosis, adenomyosis, fibroids, or very painful periods, you know that pain does not depend solely on the menstrual cycle. There is an underlying “biological terrain” characterized by chronic inflammation, altered estrogen signaling, and increased angiogenesis that drives disease progression and persistence of symptoms.

In endometriosis, endometriotic lesions can produce estrogen locally, promoting their own growth. In addition, a state of persistent chronic inflammation is maintained, and angiogenesis (formation of new blood vessels) is stimulated—this is a key process that allows lesions to survive and expand over time.

These three targets—inflammation, local estrogenic environment, and angiogenesis—are currently central in the pathophysiological approach to the disease.

2. What is resveratrol and why is it relevant in endometriosis

Resveratrol is a polyphenol naturally found in grapes, berries, and other plants. In EndoRestore™, we use trans-resveratrol, its biologically active form, at a dose designed to work synergistically with other compounds in the formula.

Resveratrol has been widely studied for its ability to:

• Activate SIRT1 and AMPK, two cellular energy and metabolic sensors associated with improved regulation of inflammation and cellular metabolic balance. This activation contributes to creating an environment less favorable to chronic inflammation and cellular stress.
  
  

• Inhibit aromatase and COX-2, two enzymes particularly relevant in endometriosis: aromatase is involved in local estrogen production within endometriotic lesions, while COX-2 is involved in prostaglandin synthesis, mediators directly linked to inflammation and pain. By modulating both, resveratrol may influence both the local hormonal environment and inflammatory and pain signaling.
  
  

• Attenuate pro-inflammatory, pro-proliferative, and pro-angiogenic pathways such as NF-κB and VEGF, which are involved in sustaining inflammation, ectopic tissue growth, and the formation of new blood vessels necessary for lesion survival.
  
  

This profile makes it a particularly interesting compound in conditions where chronic inflammation, local estrogen stimulation, and ectopic tissue growth converge, such as endometriosis.

3. Clinical evidence in pain

Available clinical research suggests that resveratrol may play a role as an adjunct in managing endometriosis-associated pain.

In a trial published in Nutrients (Kianpour et al., 2021), resveratrol supplementation was associated with a reduction in inflammatory markers and improvement in pain in women with endometriosis.

Similarly, an earlier clinical study (Mendes da Silva et al., 2017) observed improved pelvic pain outcomes in women treated with resveratrol as a complement to conventional therapy.

These findings support the idea that modulating inflammation and the biochemical environment of endometriotic tissue may translate into symptomatic improvement in clinical practice.

4. Experimental evidence: mechanisms of action

Beyond clinical outcomes, experimental studies help explain why resveratrol may be useful in endometriosis.

VEGF (vascular endothelial growth factor) is a key protein in the formation of new blood vessels. In endometriosis, its activation promotes vascularization of lesions, allowing them to persist and progress over time. In this context, animal studies have shown that resveratrol treatment can reduce the development of endometriotic lesions by modulating VEGF and various inflammatory markers (Arablou et al., 2021), reinforcing its potential role in controlling angiogenesis and the inflammatory microenvironment.

Recent reviews on resveratrol and reproductive health (Novakovic et al., 2022) and on polyphenols in endometriosis (Hipólito-Reis et al., 2022) describe effects on:

• Chronic inflammation
  
  

• Oxidative stress
  
  

• Cellular proliferation
  
  

• Angiogenesis
  
  

• Signaling pathways involved in lesion progression
  
  

Altogether, these mechanisms align with key pathophysiological targets of endometriosis: less inflammation, reduced angiogenic stimulation, and a tissue environment less favorable for lesion persistence.

5. Resveratrol within an integrative approach

Reviews on supplementation in endometriosis (Yalçın Bahat et al., 2022) position resveratrol among the compounds with the strongest scientific interest within a nutritional and complementary approach to the disease, alongside other polyphenols such as quercetin and curcumin.

It is important to understand that resveratrol is not a standalone or replacement treatment, but rather a tool that can be integrated into a multimodal strategy: personalized nutrition, stress management, adapted exercise, and medical treatment when necessary.

6. Synergies in EndoRestore™

In EndoRestore™, the active form of resveratrol is strategically combined with other compounds:

Sulforaphane

Sulforaphane is a bioactive compound known for its ability to activate the Nrf2 pathway, a regulator of detoxification and antioxidant defense systems. Through this pathway, it promotes the expression of enzymes involved in estrogen metabolism and elimination, contributing to a more balanced hormonal environment.

Resveratrol, in turn, reduces local estrogen synthesis by inhibiting aromatase, an enzyme that converts androgens into estrogens and is upregulated in endometriotic lesions.

Together, they act at two complementary levels:

• Reduced local estrogen production (resveratrol)
  
  

• Improved estrogen metabolism and elimination (sulforaphane)
  
  

This synergy helps reduce the local estrogen burden that supports lesion persistence and progression.

Quercetin

Both resveratrol and quercetin are polyphenols with demonstrated effects on key inflammatory and angiogenic pathways such as NF-κB and VEGF, making them a particularly interesting combination for modulating the inflammatory microenvironment surrounding endometriotic lesions.

Additionally, quercetin has a specific effect on mast cells, which are involved in releasing pro-inflammatory mediators and in pain sensitization. By contributing to their stabilization, quercetin may enhance the control of inflammation and endometriosis-related pain.

Furthermore, quercetin may improve the stability and bioavailability of resveratrol by modulating its metabolism, helping to prolong its active presence in the body.

6. Clinical conclusion

Resveratrol does not replace medical treatment for endometriosis. However, available evidence suggests it may be considered a nutritional support with a solid mechanistic basis and preliminary clinical data in modulating pain and inflammation.

If you are looking for an ingredient that not only targets symptoms but also intervenes in processes such as chronic inflammation, angiogenesis, and local estrogen synthesis, resveratrol is an option with growing scientific support.

When integrated into a comprehensive strategy including nutrition, rest, and moderate exercise, and formulated in synergy with other compounds as in EndoRestore™, it may contribute to more sustained symptom improvement and better quality of life.

7. References

• Kianpour M, Khademi N, Pahlavani N, et al. Effects of resveratrol on inflammatory markers and pain in women with endometriosis. Nutrients. 2021;13(4):1200.
  
  

• Mendes da Silva S, Vitale SG, Silveira GD, et al. Clinical evaluation of resveratrol for endometriosis-associated pain. Clin Exp Obstet Gynecol. 2017;44(4):568–572.
  
  

• Yalçın Bahat P, Ayhan I, Üreyen Özdemir E, İnceboz Ü, Oral E. Dietary supplements for treatment of endometriosis: A review. Acta Biomed. 2022;93(1):e2022159. PMID: 35315418.
  
  

• Novakovic R, Rajkovic J, Gostimirovic M, Gojkovic-Bukarica L, Radunovic N. Resveratrol and reproductive health. Life (Basel). 2022;12(2):294. PMID: 35207581.
  
  

• Arablou T, Hamedi S, Vafa M. Resveratrol treatment reduces the development of experimental endometriosis through modulation of VEGF and inflammatory markers. Biol Reprod. 2021;104(3):692–700.
  
  

• Hipólito-Reis M, Neto AC, Neves D, et al. Impact of curcumin, quercetin, or resveratrol on the pathophysiology of endometriosis: a systematic review. Phytother Res. 2022;36(6):2416–2433. PMID: 35583746.